{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:42:59Z","timestamp":1789796579845,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001642","name":"Glenn Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.exer.2019.107775","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T11:16:24Z","timestamp":1566558984000},"page":"107775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["FGF2-induced STAT3 activation regulates pathologic neovascularization"],"prefix":"10.1016","volume":"187","author":[{"given":"Zhenyu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Santeford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Ornitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra S.","family":"Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2019.107775_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMe058142","article-title":"Angiogenic pathways in diabetic retinopathy","volume":"353","author":"Aiello","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2019.107775_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaophthalmol.2015.5469","article-title":"What is chronic or persistent diabetic macular edema and how should it Be treated?","volume":"134","author":"Apte","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.exer.2019.107775_bib3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.exer.2019.107775_bib4","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1371\/journal.pmed.0030310","article-title":"Macrophages inhibit neovascularization in a murine model of age-related macular degeneration","volume":"3","author":"Apte","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.exer.2019.107775_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2013.02.017","article-title":"Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab","volume":"156","author":"Bakall","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107775_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91455","article-title":"GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients","volume":"2","author":"Ban","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.exer.2019.107775_bib7","doi-asserted-by":"crossref","first-page":"33407","DOI":"10.1038\/srep33407","article-title":"Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGFbeta)-dependent smooth muscle cell phenotype modulation","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2019.107775_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3","volume":"12","author":"Colvin","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exer.2019.107775_bib9","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1242\/dev.128.11.2095","article-title":"Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme","volume":"128","author":"Colvin","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.exer.2019.107775_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.exer.2019.107775_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.exer.2019.107775_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/bjo.2011.204685","article-title":"Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation","volume":"96","author":"Gasperini","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107775_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/0008-5472.671.65.3","article-title":"Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies","volume":"65","author":"Gerber","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2019.107775_bib14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1083\/jcb.77.3.774","article-title":"Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth f actor, epidermal growth factor, and thrombin","volume":"77","author":"Gospodarowicz","year":"1978","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exer.2019.107775_bib15","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107775_bib16","doi-asserted-by":"crossref","first-page":"H559","DOI":"10.1152\/ajpheart.00758.2015","article-title":"Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury","volume":"310","author":"House","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.exer.2019.107775_bib17","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1172\/JCI32430","article-title":"Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice","volume":"117","author":"Kelly","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.exer.2019.107775_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng0298-136","article-title":"An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination","volume":"18","author":"Meyers","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exer.2019.107775_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107775_bib20","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1172\/JCI35298","article-title":"The FGF system has a key role in regulating vascular integrity","volume":"118","author":"Murakami","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.exer.2019.107775_bib21","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1038\/ncomms8847","article-title":"IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis","volume":"6","author":"Nakamura","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2019.107775_bib22","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1073\/pnas.1324235111","article-title":"Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis","volume":"111","author":"Oladipupo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2019.107775_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"10.1016\/j.exer.2019.107775_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tem.2013.10.007","article-title":"Eyeballing cholesterol efflux and macrophage function in disease pathogenesis","volume":"25","author":"Sene","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.exer.2019.107775_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molmed.2014.10.005","article-title":"Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye","volume":"21","author":"Sene","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.exer.2019.107775_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","article-title":"Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration","volume":"17","author":"Sene","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.exer.2019.107775_bib27","doi-asserted-by":"crossref","first-page":"e69552","DOI":"10.1371\/journal.pone.0069552","article-title":"Choroid sprouting assay: an ex vivo model of microvascular angiogenesis","volume":"8","author":"Shao","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.exer.2019.107775_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/aos.13802","article-title":"A meta-analysis of patients with treatment-resistant macular oedema secondary to retinal vein occlusions following switching to aflibercept","volume":"97","author":"Spooner","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2019.107775_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00417-009-1058-x","article-title":"Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis","volume":"247","author":"Stahl","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107775_bib30","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/emboj\/cdg169","article-title":"FGFR1 is independently required in both developing mid- and hindbrain for sustained response to isthmic signals","volume":"22","author":"Trokovic","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.exer.2019.107775_bib31","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.2010.33.2312","article-title":"Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling","volume":"29","author":"Wagle","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.exer.2019.107775_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1242\/dev.125.4.753","article-title":"Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction","volume":"125","author":"Xu","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.exer.2019.107775_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1097-4652(200010)185:1<135::AID-JCP13>3.0.CO;2-Y","article-title":"Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina","volume":"185","author":"Yamada","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.exer.2019.107775_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajo.2013.03.030","article-title":"Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration","volume":"156","author":"Yonekawa","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107775_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nm0298-201","article-title":"Fibroblast growth factor 2 control of vascular tone","volume":"4","author":"Zhou","year":"1998","journal-title":"Nat. Med."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351930452X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351930452X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:02:49Z","timestamp":1757998969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448351930452X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":35,"alternative-id":["S001448351930452X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2019.107775","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGF2-induced STAT3 activation regulates pathologic neovascularization","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2019.107775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107775"}}